Monday
Semiconductors beyond Nvidia, Book club is back & introducing: Pimp my Portfolio
Nvidia, Nvidia, Nvidia, Nvidia. It seems like every financial media company has to hit a quota of mentions about the technology giant. That hopefully fills ours.
Tuesday
$100 challenge: Sam’s making money with Lego
The $100 challenge is back for 2024. The premise of these episodes is simple: $100 invested each month at the market’s average return of 8% for 40 years is $350,000.
Little steps over a long period can make a big difference.
How much do I need to start a business? | Taboo money chats with Lucy Wark
Do you have a million-dollar idea? Always dreamed of working for yourself? Starting a business can be one of the most exciting and rewarding experiences, but where do you begin? Actually figuring out how to start your own business can be tricky. Do you quit your job so you have time to grow your idea? Do you forego your house deposit to invest into your dream business? There’s a lot to consider before you officially take the leap, and you need a game plan!
Buy or Sell: Adam Keily with Julian McCormack
For the first time in 2024, Adam Keily is back on the podcast with his latest Buy or Sell episode. He is joined by Julian McCormack of Platinum Asset Management to go through some of the companies he’s buying and selling.
Wednesday
115 – Market Pump: Record ETFs, Bitcoin’s DeFi Rise & Uniswap’s Leap
Dive into the pulse of cryptocurrency this week on the Crypto Curious podcast, where we talk about the latest market surges, including Bitcoin’s remarkable ETF records and its strategic moves into the DeFi space.
Thursday
Ren’s 2024 portfolio, ETF question & expert stock pitch: Australian Financial Group
Wondering how we set up our portfolios here at Equity Mates? In this episode we cover how we’re investing for 2024, across both our core and satellite portfolios.
Friday
Market Update | How Might New Superannuation Rules Affect You?
In this episode, the order pad returns as two stocks that were pitched back in February 2022 get revisited. For one, it’s time to take profits. For the other, it’s time to double down.
Uncovered: Emyria – Bringing psychedelic-assisted therapies to Australia
Uncovered is our series where we take a closer look at some of the Aussie companies that get less analyst coverage and media attention. And today’s episode is a cracker.
Emyria – Bringing psychedelic-assisted therapies to Australia
We speak to Dr Michael Winlo, CEO and Managing Director of Emyria (ASX: EMD) about the recent rescheduling of MDMA and psilocybin and his company’s efforts to introduce psychedelic-assisted therapy into Australia.